Surges

JHVEPhoto Longeveron (NASDAQ:LGVN) shares climbed in the morning hours Wednesday after the U.S. FDA granted Regenerative Medicine Advanced Therapy (RMAT) designation for its lead asset Lomecel-B as a treatment for mild Alzheimer’s. Targeted at regenerative medicines, including cell therapies such as Lomecel-B, the RMAT designation offers regulatory benefits similar toContinue Reading

U.Today – U.Today has prepared a summary of the top three news stories over the weekend. Schiff predicts price will keep falling for several years On Friday, June 21, Peter Schiff heaped yet another portion of criticism on Bitcoin, the flagship cryptocurrency. In his X post, Schiff noted that sinceContinue Reading